Remote Patient Monitoring

Objective: Heart failure (HF) presents a healthcare challenge due to its high comorbidity burden, aging patient population and frequent hospitalizations. Remote monitoring offers a promising approach to managing HF patients by early detection of health deterioration. Developing autonomous systems to detect signs of worsening in telemonitoring data is of interest to reduce the workload of healthcare personnel. Methods: We propose the TRACER model, a Transformer with Contrastive Event Representation, designed to predict timelines leading to rare hospitalization events in low-resolution and irregularly sampled telemonitoring data. TRACER incorporates time-aware embeddings for each biomarker, contrastive pre-training to enhance anomaly detection via representation learning, and independent binary classifiers for detection. We used measurement data containing remotely recorded biomarker sequences from 276 HF patients segmented into overlapping windows based on temporal rules, and labeled the windows based on the occurrence of HF relevant hospitalizations at the latter edge of the window. Results: TRACER was able to correctly predict 66.7% timelines leading up to HF hospitalizations in the highly imbalanced real-world dataset with an overestimation of 7.9%. Reformulating the training of TRACER as an event detection problem improved the predictive performance compared with training directly on forecasting windows, enabling more effective use of the limited hospitalization events. Conclusion: TRACER demonstrated superior performance in detecting signs of worsening status in real-world telemonitoring data compared to the other tested models. Significance: TRACER shows promise in identifying signs of clinical deterioration that allow for alerts to be generated to provide counteractive treatment in patients with HF.

Background: Digital health technologies allow for frequent, remote gait monitoring in people with multiple sclerosis (MS). However, to differentiate daily variability from actual disease progression in longitudinal data, established minimal clinically important differences (MCID) are required. Currently, there is limited literature defining these thresholds for digital gait metrics. Objective: To establish MCIDs for digital gait measures reflecting progression in MS. Methods: Digital gait measures were captured via daily, remote, smartphone-based Two-Minute Walk Tests in CONSONANCE (NCT03523858), a phase 3b study of ocrelizumab in progressive MS. Using an anchor-based approach, median changes from baseline at Week 96 on digital gait measures were computed for patients showing clinically meaningful worsening on either Timed 25-Foot Walk, Ambulation Score, Expanded Disability Status Scale, or 12-item Multiple Sclerosis Walking Scale. These changes were subsequently triangulated to derive the MCID estimates. Results: 243 patients with progressive MS (female: n=125 (51%); mean [SD] age: 49.3 [9.3]; mean [SD] EDSS: 4.8 [1.4]) had digital gait data available at baseline and Week 96. Median changes were generally consistent across anchors. Triangulated MCIDs are: Step Velocity = -0.16 m/s, Step Velocity Scaled to Walking Time = -0.18 m/s, Step Duration = 0.06 s, Step Length = -0.07 m, Total Number of Steps = -28, and Total Distance Walked = -24 m. Conclusion: These MCIDs provide a framework for interpreting meaningful gait changes and integrating digital measures into MS outcome evaluation. Beyond facilitating novel clinical trial endpoints to evaluate treatment efficacy, they enable objective, real-world monitoring to advance personalized patient care.

Remote patient monitoring depends on patient-reported data to capture the subjective dimension of recovery that devices cannot measure. The Quality of Recovery (QoR-15) survey is the gold-standard instrument for this purpose. It was designed and validated for occasional in-hospital assessment, yet remote monitoring now administers it to patients daily. In our own post-surgical deployment, only 55% of patients submitted the survey more than 14 days of 30 monitoring days. We developed QoR-compact, a five-item daily input for the RPM prediction pathway. Setting a deployment-driven target of one-third of the daily items, we exhaustively evaluated all 3,003 five-question subsets of the QoR-15 and tested whether the best of them matches the full instrument in predicting near-term postoperative recovery severity. QoR-compact achieves a mean AUC-ROC of 0.968 (95% CI 0.915-0.988), statistically comparable to the 0.964 baseline obtained with one-third of the items. Patient-level backtesting indicates that it tracks readmission events as faithfully as the full form. Its five items span the physical and psychological axes of recovery: Q3 (feeling rested), Q9 (feeling comfortable and in control), Q10 (general well-being), Q12 (severe pain), and Q14 (feeling worried or anxious). The QoR-15 remains the gold-standard measure of recovery; QoR-compact complements it as a shorter daily input designed for prediction. This parity provides the basis for a prospective study of whether a lighter daily input is, in turn, completed more consistently. External validation on larger cohorts is required before clinical use.

CARE-link is an open-source, web-based clinical support platform designed to improve the management of gestational diabetes by linking clinicians and patients through an LLM-mediated workflow. The system aggregates patient-generated data outside the hospital, summarizes relevant clinical information, and delivers context-aware decision support to clinicians. For patients, CARE-link provides clear explanations of management plans and delivers timely lifestyle guidance through a WhatsApp interface. The integrated dual-facing design aims to promote continuous monitoring, support individualized care, and reduce the burden of in-clinic follow-ups. Built with a modular architecture, the platform can be adapted to other chronic conditions requiring longitudinal tracking and behavioral support. CARE-link has the potential to enhance clinical oversight, promote patient compliance, and strengthen continuity of care particularly in resource-constrained settings.

We present Veritas-RPM, a provenance-guided multi-agent architecture comprising five processing layers: VeritasAgent (ground-truth assembly), SentinelLayer (anomaly detection), DirectorAgent (specialist routing), six domain Specialist Agents, and MetaSentinelAgent (conflict resolution and final decision). We construct a 98-case synthetic taxonomy of false-positive scenarios derived from documented RPM patterns. Synthetic patient epochs (n = 530) were generated directly from taxonomy parameters and processed through the pipeline. Ground-truth labels are known for all cases. Performance is reported as True Suppression Rate (TSR), False Escalation Rate (FER), and Indeterminate Rate (INDR).

Background: Remote patient monitoring (RPM) generates vast data, yet landmark trials (Tele-HF, BEAT-HF) failed because data volume overwhelmed clinical staff. While TIM-HF2 showed 24/7 physician-led monitoring reduces mortality by 30%, this model remains prohibitively expensive and unscalable. Methods: We developed Sentinel, an autonomous AI agent using Model Context Protocol (MCP) for contextual triage of RPM vitals via 21 clinical tools and multi-step reasoning. Evaluation included: (1) self-consistency (100 readings x 5 runs); (2) comparison against rule-based thresholds; and (3) validation against 6 clinicians (3 physicians, 3 NPs) using a connected matrix design. A leave-one-out (LOO) analysis compared the agent against individual clinicians; severe overtriage cases underwent independent physician adjudication. Results: Against a human majority-vote standard (N=467), the agent achieved 95.8% emergency sensitivity and 88.5% sensitivity for all actionable alerts (85.7% specificity). Four-level exact accuracy was 69.4% (quadratic-weighted kappa=0.778); 95.9% of classifications were within one severity level. In LOO analysis, the agent outperformed every clinician in emergency sensitivity (97.5% vs. 60.0% aggregate) and actionable sensitivity (90.9% vs. 69.5%). While disagreements skewed toward overtriage (22.5%), independent adjudication of severe gaps (>=2 levels) validated agent escalation in 88-94% of cases; consensus resolution validated 100%. The agent showed near-perfect self-consistency (kappa=0.850). Median cost was $0.34/triage. Conclusions: Sentinel triages RPM vitals with sensitivity exceeding individual clinicians. By automating systematic context synthesis, Sentinel addresses the core limitation of prior RPM trials, offering a scalable path toward the intensive monitoring shown to reduce mortality while maintaining a clinically defensible overtriage profile.

Remote monitoring of heart failure (HF) via speech signals provides a non-invasive and cost-effective solution for long-term patient management. However, substantial inter-individual heterogeneity in vocal characteristics often limits the accuracy of traditional cross-sectional classification models. To address this, we propose a Longitudinal Intra-Patient Tracking (LIPT) scheme designed to capture the trajectory of relative symptomatic changes within individuals. Central to this framework is a Personalised Sequential Encoder (PSE), which transforms longitudinal speech recordings into context-aware latent representations. By incorporating historical data at each timestamp, the PSE facilitates a holistic assessment of the clinical trajectory rather than modelling discrete visits independently. Experimental results from a cohort of 225 patients demonstrate that the LIPT paradigm significantly outperforms the classic cross-sectional approaches, achieving a recognition accuracy of 99.7% for clinical status transitions. The model's high sensitivity was further corroborated by additional follow-up data, confirming its efficacy in predicting HF deterioration and its potential to secure patient safety in remote, home-based settings. Furthermore, this work addresses the gap in existing literature by providing a comprehensive analysis of different speech task designs and acoustic features. Taken together, the superior performance of the LIPT framework and PSE architecture validates their readiness for integration into long-term telemonitoring systems, offering a scalable solution for remote heart failure management.

Continuous monitoring of vital signs in Pediatric Intensive Care Units (PICUs) is essential for early detection of clinical deterioration and effective clinical decision-making. However, contact-based sensors such as pulse oximeters may cause skin irritation, increase infection risk, and lead to patient discomfort. Remote photoplethysmography (rPPG) offers a contactless alternative to monitor heart rate using facial video, but remains underutilized in PICUs due to motion artifacts, occlusions, variable lighting, and domain shifts between laboratory and clinical data. We introduce a self-supervised pretraining framework for rPPG estimation in the PICU setting, based on a progressive curriculum strategy. The approach leverages the VisionMamba architecture and integrates an adaptive masking mechanism, where a lightweight Mamba-based controller assigns spatiotemporal importance scores to guide probabilistic patch sampling. This strategy dynamically increases reconstruction difficulty while preserving physiological relevance. To address the lack of labeled clinical data, we adopt a teacher-student distillation setup. A supervised expert model, trained on public datasets, provides latent physiological guidance to the student. The curriculum progresses through three stages: clean public videos, synthetic occlusion scenarios, and unlabeled videos from 500 pediatric patients. Our framework achieves a 42% reduction in mean absolute error relative to standard masked autoencoders and outperforms PhysFormer by 31%, reaching a final MAE of 3.2 bpm. Without explicit region-of-interest extraction, the model consistently attends to pulse-rich areas and demonstrates robustness under clinical occlusions and noise.

The rising prevalence of chronic wounds, especially in aging populations, presents a significant healthcare challenge due to prolonged hospitalizations, elevated costs, and reduced patient quality of life. Traditional wound care is resource-intensive, requiring frequent in-person visits that strain both patients and healthcare professionals (HCPs). Thus, we present WoundAIssist, a patient-centered, AI-driven mobile application supporting telemedical wound care. WoundAIssist enables patients to document wounds at home via photographs and questionnaires, while physicians remain engaged in the care process through remote monitoring and video consultations. A distinguishing feature is an integrated lightweight deep learning model for on-device wound segmentation, guiding users during image capture. Combined with patient-reported data and server-side AI analysis, this enables continuous monitoring of wound healing progression. Developed through an iterative, user-centered process involving patients and domain experts, WoundAIssist prioritizes an user-friendly design, particularly for elderly patients. A conclusive usability study with patients and dermatologists reported excellent usability, good app quality, and favorable perceptions of the AI-driven wound recognition. Our main contribution is two-fold: (I) the development and (II) evaluation of WoundAIssist, an easy-to-use yet comprehensive telehealth solution designed to bridge the gap between patients and HCPs. Additionally, we synthesize design insights for remote patient monitoring apps, derived from over three years of interdisciplinary research, that may inform the development of similar digital health tools across clinical domains.